BMO
AVNS

Beck Mack & Oliver’s Avanos Medical AVNS Stock Holding History

Beck Mack & Oliver’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-8,934
Closed -$298K – 286
2015
Q4 		$298K Sell
8,934
-640
-7% -$19.9K 0.01% 230
2015
Q3 		$272K Sell
9,574
-798
-8% -$27.8K 0.01% 265
2015
Q2 		$420K Sell
10,372
-729
-7% -$32.7K 0.01% 245
2015
Q1 		$546K Sell
11,101
-1,075
-9% -$49.8K 0.01% 228
2014
Q4 		$554K Buy
+12,176
New +$478K 0.01% 230

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return

Beck Mack & Oliver's AVNS Position: Q1 2016 in Review

Beck Mack & Oliver sold out of Avanos Medical (AVNS) in Q1 2016, closing a stake of 8,934 shares — an estimated $298K sold.

Beck Mack & Oliver first reported a position in AVNS in Q4 2014 and held it in 5 quarters. The position peaked at $554K in Q4 2014. 333 funds tracked by Wall St. Rank hold AVNS as of Q1 2016.

  • Beck Mack & Oliver reported no remaining Avanos Medical position as of Q1 2016 after selling out during the quarter.
  • Beck Mack & Oliver sold 8,934 Avanos Medical shares in Q1 2016, an estimated $298K.
  • Beck Mack & Oliver first reported a position in Avanos Medical in Q4 2014 and held it in 5 quarters.
  • Beck Mack & Oliver's Avanos Medical position peaked at $554K in Q4 2014.
  • 333 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2016.

Based on Beck Mack & Oliver's 13F filing for Q1 2016, filed 27 Apr 2016.